IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
Hospital Israelita Albert Einstein
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center
Tufts Medical Center